Abstract
Measuring joint range of motion has traditionally occurred with a universal goniometer, inclinometer, or expensive laboratory systems. The popularity of the inertial measuremen unit (IMU) is growing, enabling the small even single portable device to measure the range of motion. Until now, they were not used to assess hip joint range of motion. Our study aimed to check the validity of IMU in assessing a hip range of motion and compare them to other measurement devices - universal goniometer and inclinometer. Twenty participants completed three hip movements (flexion in standing and prone internal and external rotation) on both hips. Two testers independently assessed each movement with a goniometer, digital inclinometer, and IMU at different time points. To assess the agreement of active hip ROM between devices, Intraclass Correlation Coefficient (ICC) and Bland-Altman analysis were used. Furthermore, inter-rater and intra-rater reliability were also assessed by using ICC and Bland-Altman analysis. Limits of agreement (LOA) were calculated using Bland-Altman plots. IMU showed good to excellent validity compared with the goniometer and digital inclinometer for all tested movements with ICCs ranging from 0.87-0.99 and LOAs <9°. Intra-rater reliability was good-to-excellent for all tested movements for all devices, with ICCs ranging from 0.87 to 0.99 and LOAs < 7°. Inter-rater reliability was lower and comparable for all measurement methods: moderate flexion (ICC: 0.58-0.59), LOAs <22,4 and poor for both rotations (ICC:-0.33-0.04), and LOAs < 7.8°). The present study shows that a single inertial measurement unit (RSQ Motion) could be successfully used to assess the active hip range of motion in healthy subjects with comparable to other methods accuracy.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Bioethical Committee of the University of Medical Scienc-es in Poznań, Poland (no.13/21) and met the criteria of the Declaration of Helsinki.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
maciej.niedziela{at}rehasport.pl (M.N), p.lubiatowski{at}rehasport.pl(P.L) tomasz.piontek{at}rehasport.pl (T.P.)
Data Availability
All data produced in the present study are available upon reasonable request to the authors